NCT06999798 2026-02-12An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 TrialMayo ClinicPhase 1 Recruiting20 enrolled
NCT05319873 2025-05-13Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast CancerJonsson Comprehensive Cancer CenterPhase 1/2 Recruiting18 enrolled